Amtagvi

Drug Iovance Biotherapeutics, Inc.
Total Payments
$6.5M
Transactions
1,418
Doctors
409
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $6.5M 1,418 409

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $6.4M 816 98.2%
Honoraria $39,995 12 0.6%
Consulting Fee $33,845 16 0.5%
Food and Beverage $26,679 522 0.4%
Travel and Lodging $14,142 52 0.2%

Payments by Type

Research
$6.4M
816 transactions
General
$114,661
602 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
101623 Iovance Biotherapeutics, Inc. $2.2M 0
81990 Iovance Biotherapeutics, Inc. $1.2M 0
117145 Iovance Biotherapeutics, Inc. $827,238 0
NCT03108495 Iovance Biotherapeutics, Inc. $786,417 0
IIT-2022-LDTIL Iovance Biotherapeutics, Inc. $324,622 0
NCT05361174 Iovance Biotherapeutics, Inc. $322,918 0
NCT02360579 Iovance Biotherapeutics, Inc. $181,731 0
IOV-EAP-401 Iovance Biotherapeutics, Inc. $164,400 0
131462 Iovance Biotherapeutics, Inc. $141,705 0
123745 Iovance Biotherapeutics, Inc. $98,417 0
22-109 Iovance Biotherapeutics, Inc. $73,015 0
Endometrial Preclinical Research: OU202308LH-IOVANCE Iovance Biotherapeutics, Inc. $56,170 0
IOV-EAP-402 Iovance Biotherapeutics, Inc. $20,000 0
MCC-19837 Iovance Biotherapeutics, Inc. $20,000 0

Top Doctors Receiving Payments for Amtagvi — Page 5

Doctor Specialty Location Total Records
, MD Hematology & Oncology Houston, TX $89.03 1
James Isaacs Medical Oncology Cleveland, OH $89.02 1
, M.D Medical Oncology Boston, MA $89.02 1
, MD Hematology & Oncology Kingwood, TX $83.30 2
, APRN Student in an Organized Health Care Education/Training Program Rochester, MN $72.35 1
, APRN Nurse Practitioner Rochester, MN $72.35 1
Lucy Holmes Family Rochester, MN $72.35 1
, FNP-C Family Palestine, TX $72.35 1
, PA Physician Assistant Rochester, MN $72.35 1
, PA Physician Assistant Rochester, MN $72.35 1
, FNP Family Knoxville, TN $72.35 1
, PA Physician Assistant Rochester, MN $72.34 1
, MD Hematology Pittsburgh, PA $70.34 1
, MD Hematology & Oncology Pittsburgh, PA $70.34 1
, MD Emergency Medicine Gardnerville, NV $68.85 1
, MD Surgical Oncology Berkeley, CA $68.85 1
, MD Internal Medicine Duarte, CA $67.69 1
, MD Internal Medicine San Diego, CA $67.40 1
, M.D Surgery Phoenix, AZ $65.94 1
, MD Surgery Houston, TX $65.94 1
, M.D Surgical Oncology Charlottesville, VA $65.94 1
, MD Surgery Jacksonville, FL $65.94 1
, MD Gastroenterology Mesquite, TX $65.93 1
, MD Surgical Oncology Chicago, IL $65.93 1
, MD Surgical Oncology Chicago, IL $65.93 1

About Amtagvi

Amtagvi is a drug associated with $6.5M in payments to 409 healthcare providers, recorded across 1,418 transactions in the CMS Open Payments database. The primary manufacturer is Iovance Biotherapeutics, Inc..

Payment data is available from 2024 to 2024. In 2024, $6.5M was paid across 1,418 transactions to 409 doctors.

The most common payment nature for Amtagvi is "Unspecified" ($6.4M, 98.2% of total).

Amtagvi is associated with 14 research studies, including "101623" ($2.2M).